日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Global burden and trends of breast cancer: GLOBOCAN 2022 estimates of incidence and mortality in 185 countries

全球乳腺癌负担和趋势:GLOBOCAN 2022 对 185 个国家乳腺癌发病率和死亡率的估计

Gu, Hao; Wang, Ruofan; Beeraka, Narasimha M; Lu, Pengwei; Zhao, Xiang; Li, Lianghui; Liu, Yuqi; Kandula, Dilipkumar Reddy; Fan, Ruitai; Gayathri, Thainala; Nikolenko, Vladimir N; Nagalakshmi, Allaka; Basappa, Basappa; Liu, Junqi

A novel drug prejudice scaffold-imidazopyridine-conjugate can promote cell death in a colorectal cancer model by binding to β-catenin and suppressing the Wnt signaling pathway

一种新型药物靶向支架——咪唑并吡啶缀合物,可通过与β-catenin结合并抑制Wnt信号通路,促进结直肠癌模型中的细胞死亡。

Yang, Min Hee; Basappa, Basappa; Deveshegowda, Suresha N; Ravish, Akshay; Mohan, Arunkumar; Nagaraja, Omantheswara; Madegowda, Mahendra; Rangappa, Kanchugarakoppal S; Deivasigamani, Amudha; Pandey, Vijay; Lobie, Peter E; Hui, Kam Man; Sethi, Gautam; Ahn, Kwang Seok

Inhibition of TFF3 synergizes with c-MET inhibitors to decrease the CSC-like phenotype and metastatic burden in ER+HER2+ mammary carcinoma.

抑制 TFF3 与 c-MET 抑制剂协同作用,可降低 ER+HER2+ 乳腺癌的 CSC 样表型和转移负荷

He Chuyu, Wang Xuejuan, Chiou Yi-Shiou, Basappa Basappa, Zhu Tao, Pandey Vijay, Lobie Peter E

Targeting the epigenome and tumor heterogeneity: advances in immunotherapy for chemoresistant metastatic colorectal cancer

靶向表观基因组和肿瘤异质性:化疗耐药性转移性结直肠癌免疫治疗的进展

Cao, Yu; Beeraka, Narasimha M; Efetov, Sergey K; Liu, Zheng; Otabekov, Akmalbek A; Basappa, Basappa; Wang, Wensheng; Ma, Dan

Dual action of pyrimidine derivatives: Targeting tamoxifen resistance in breast cancer

嘧啶衍生物的双重作用:靶向治疗乳腺癌中的他莫昔芬耐药性

Yuan, Jie; Wang, Geng; Beeraka, Narasimha M; Zhang, Hua; Wang, Qun; Zhang, Danfeng; Wang, Minghua; Ravish, Akshay; Chinnathambi, Arunachalam; Alharbi, Sulaiman Ali; Rangappa, Kanchugarakoppal S; Nikolenko, Vladimir N; Basappa, Basappa; Yang, Li

TFF3 facilitates dormancy of anti-estrogen treated ER+ mammary carcinoma

TFF3促进抗雌激素治疗的ER+乳腺癌细胞进入休眠状态

Chen, Shu; Zhang, Xi; Basappa, Basappa; Zhu, Tao; Pandey, Vijay; Lobie, Peter E

Reply to: "The non-cytotoxic small molecule NPB does not inhibit BAD phosphorylation and forms colloidal aggregates".

回复:“无细胞毒性小分子NPB不抑制BAD磷酸化,并形成胶体聚集体”

Zhang Xi, Basappa Basappa, Lobie Peter E, Pandey Vijay

Concurrent inhibition of pBADS99 synergistically improves MEK inhibitor efficacy in KRAS(G12D)-mutant pancreatic ductal adenocarcinoma.

同时抑制 pBADS99 可协同提高 MEK 抑制剂在 KRAS(G12D) 突变型胰腺导管腺癌中的疗效

Tan Yan Qin, Sun Bowen, Zhang Xi, Zhang Shuwei, Guo Hui, Basappa Basappa, Zhu Tao, Sethi Gautam, Lobie Peter E, Pandey Vijay

Recent developments in Achilles tendon risk-analyzing rupture factors for enhanced injury prevention and clinical guidance: Current implications of regenerative medicine

跟腱断裂风险分析因素的最新进展,旨在加强损伤预防和临床指导:再生医学的当前意义

Sankova, Maria V; Beeraka, Narasimha M; Oganesyan, Marine V; Rizaeva, Negoriya A; Sankov, Aleksey V; Shelestova, Olga S; Bulygin, Kirill V; Vikram Pr, Hemanth; Barinov, A N; Khalimova, A K; Padmanabha Reddy, Y; Basappa, Basappa; Nikolenko, Vladimir N

Emerging insights into epigenetics and hematopoietic stem cell trafficking in age-related hematological malignancies

年龄相关血液恶性肿瘤中表观遗传学和造血干细胞迁移的新见解

Xinyi, Yang; Vladimirovich, Reshetov Igor; Beeraka, Narasimha M; Satyavathi, Allaka; Kamble, Dinisha; Nikolenko, Vladimir N; Lakshmi, Allaka Naga; Basappa, Basappa; Reddy Y, Padmanabha; Fan, Ruitai; Liu, Junqi